Using artificial intelligence to improve endoscopic ultrasound for pancreatic diseases
Artificial Intelligence in Endoscopic Ultrasound
This study is testing whether an artificial intelligence system can help doctors find problems in the pancreas during ultrasound exams to improve diagnosis and reduce mistakes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 310 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Orlando Health, Inc. Academic / other |
| Locations | 1 site (Orlando, Florida) |
| Trial ID | NCT06564571 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of an artificial intelligence system in detecting pancreatic abnormalities during endoscopic ultrasound (EUS) procedures. EUS allows for detailed visualization of the pancreas and surrounding organs, aiding in the diagnosis of conditions like pancreatic cancer. The study will assess whether the AI can accurately identify abnormalities that trained endoscopists also recognize, potentially leading to a platform that enhances diagnostic accuracy and reduces the learning curve for practitioners. By correlating AI findings with expert evaluations, the research seeks to minimize human error in interpreting ultrasound images.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are scheduled to undergo endoscopic ultrasound examinations.
Not a fit: Patients under 18 years of age will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and efficient diagnoses of pancreatic diseases, improving patient outcomes.
How similar studies have performed: While the use of AI in medical imaging is gaining traction, this specific application in endoscopic ultrasound for pancreatic conditions is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Any patient undergoing endoscopic ultrasound examination Exclusion Criteria: * Age \< 18 years
Where this trial is running
Orlando, Florida
- Orlando Health — Orlando, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Shyam Varadarajulu, MD — Orlando Health, Digestive Health Institute
- Study coordinator: Shyam Varadarajulu, MD
- Email: shyam.varadarajulu@orlandohealth.com
- Phone: 321-841-2431
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.